TSS
CABA icon

Two Sigma Securities’s Cabaletta Bio CABA Stock Holding History

Two Sigma Securities’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.9K Buy
+26,663
New +$87.7K 0.01% 1328
2025
Q3 		– Sell
-16,491
Closed -$25.1K – 1444
2025
Q2 		$25.1K Buy
+16,491
New +$25.7K ﹤0.01% 1177
2022
Q4 		– Sell
-13,594
Closed -$9K – 2626
2022
Q3 		$9K Buy
+13,594
New +$16.4K ﹤0.01% 2412

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Two Sigma Securities's CABA Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Cabaletta Bio (CABA) in Q2 2026: 26,663 shares worth $82.9K. The stake represents 0.01% of the portfolio and ranks #1328 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CABA as recently as Q2 2025.

Two Sigma Securities first reported a position in CABA in Q3 2022 and has held it in 3 quarters since. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Two Sigma Securities held 26,663 shares of Cabaletta Bio worth $82.9K as of Q2 2026.
  • Cabaletta Bio was a new Two Sigma Securities position in Q2 2026.
  • Cabaletta Bio made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1328 holding.
  • Two Sigma Securities first reported a position in Cabaletta Bio in Q3 2022 and has held it in 3 quarters since.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.